基线透析与血浆置换对ANCA相关性血管炎肾预后的影响
该回顾性多中心研究纳入394例活检证实的ANCA相关性血管炎肾受累患者,评估基线需透析者1年内死亡或终末期肾病的复合终点。基线透析者复合终点发生率为57.1%,显著高于非透析者的10.0%(P<0.001);MPO-ANCA、高组织学肾脏风险评分和基线透析需求与不良预后独立相关,而血浆置换与降低复合终点风险独立相关。
要点
- 基线需透析者1年死亡或ESKD风险显著增高(OR 10.91)。
- MPO-ANCA和高组织学肾脏风险评分亦为独立危险因素。
- 基线透析患者中49.5%在1年时脱离透析,血浆置换与更好预后相关。
核心结论
- 基线需透析、MPO-ANCA阳性和高组织学肾脏风险评分与1年死亡或ESKD复合终点独立相关。
- 基线透析患者近半数在1年时脱离透析,接受血浆置换者预后更好。
研究设计与样本
- 回顾性多中心研究,纳入394例活检证实的ANCA相关性血管炎肾受累患者。
- 主要终点为1年死亡或终末期肾病复合终点。
主要发现
- 基线透析者105例(26.6%),其中60例(57.1%)达到复合终点,非透析者29例(10.0%)达到复合终点(P<0.001)。
- 多因素分析显示MPO-ANCA(OR 3.60,95%CI 1.79-7.60)和高基线组织学肾脏风险评分(OR 1.29,95%CI 1.17-1.44)与复合终点独立相关。
- 基线需透析与复合终点关联最强(OR 10.91,95%CI 5.52-22.70)。
- 基线透析后存活的91例患者中,45例(49.5%)在1年时脱离透析。
- 血浆置换与复合终点风险降低独立相关(OR 0.23,95%CI 0.05-0.80)。
临床怎么用
- 对基线需透析的AAV肾受累患者,应评估MPO-ANCA状态和组织学肾脏风险评分以判断预后。
- 血浆置换可能改善基线透析患者的肾脏预后,但需结合个体情况权衡。
局限性
- 回顾性研究设计可能存在选择偏倚和混杂因素。
- 原文未报告血浆置换的具体方案、时机及不良事件。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The identification of prognostic factors for renal failure in antineutrophil cytoplasmic autoantibody (ANCA)-associated vasculitis (AAV) remains a challenge. The benefit of plasma exchange (PLEX) has been questioned, and the target population remains to be defined. We investigated the outcome of patients requiring renal replacement therapy (RRT) at baseline and factors associated with their prognosis at 1 year. METHODS: This retrospective multicenter study evaluated the 1-year composite end point of death or end-stage kidney disease (ESKD) in patients with biopsy-proven renal AAV involvement. RESULTS: Of the 394 patients included, 105 (26.6%) were on dialysis at baseline. Of these, 60 (57.1%) reached the composite end point compared with 29 patients (10.0%) who were not on RRT at baseline (P < 0.001). On multivariate analysis, age and sex were not associated with the composite outcome (P = 0.945 and P = 0.154, respectively); however, myeloperoxidase (MPO)-ANCA was (odds ratio [OR]: 3.60; 95% confidence interval [CI]: 1.79-7.60), as was a high baseline histologic renal risk score (OR: 1.29; 95% CI 1.17-1.44). The most strongly associated factor remained the need for dialysis at baseline (OR: 10.91; 95% CI: 5.52-22.70). Of the 91 patients surviving after requiring dialysis at baseline, 45 were weaned from RRT (49.5%) at 1 year, and PLEX was independently associated with a reduced risk of the composite outcome (OR: 0.23, 95% CI: 0.05-0.80). CONCLUSION: MPO-ANCA, need for dialysis, and high histological renal risk score at baseline were associated with the 1-year composite end point of death or ESKD. Almost half of the patients on dialysis at baseline were off dialysis at 1 year, with a better prognosis in those who had received PLEX.
引用
- Vignac M, Nezam D, Grolleau F, et al. Effect of Baseline Dialysis and Plasma Exchange on Renal Prognosis in Patients With Antineutrophil Cytoplasmic Autoantibody-Associated Vasculitis. Kidney Int Rep. 2025. PMID: 41426042. doi:10.1016/j.ekir.2025.09.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。